Signe Regner Michaelsen
Postdoc
Kristensen Group
Ole Maaløes Vej 5
2200 København N.
1 - 1 out of 1Page size: 10
- 2017
- Published
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients
Urup, T., Staunstrup, L. M., Michaelsen, Signe Regner, Vitting-Seerup, K., Bennedbæk, M., Toft, A., Olsen, L. R., Jønson, L., Issazadeh-Navikas, Shohreh, Broholm, H., Hamerlik, P., Poulsen, H. S. & Lassen, Ulrik Niels, 18 Apr 2017, In: BMC Cancer. 17, 10 p., 278.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 108812376
Most downloads
-
223
downloads
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
114
downloads
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
102
downloads
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B
Research output: Contribution to journal › Journal article › Research › peer-review
Published